CRINETICS PHARMACEUTICALS IN

Ticker: CRNX CUSIP: 22663K107 Class: EQTY

Bain Capital Life Sciences Investors, LLC's Holding History (CIK: 0001703031)

Note: Option positions (PUT/CALL) are excluded.

Q3 2023
Shares 1,275,552 Value ($000) $37,935 Avg Close $20.61 Range $15.76 - $31.00
Q2 2023
Shares 2,305,558 Value ($000) $41,546 Avg Close $19.94 Range $15.50 - $24.58
Q1 2023
Shares 2,305,558 Value ($000) $37 Avg Close $18.51 Range $15.23 - $21.65
Q4 2022
Shares 2,305,558 Value ($000) $42 Avg Close $17.62 Range $15.37 - $19.97
Q3 2022
Shares 2,305,558 Value ($000) $45,281 Avg Close $20.39 Range $17.79 - $22.85
Q2 2022
Shares 2,305,558 Value ($000) $42,999 Avg Close $19.96 Range $15.91 - $27.86
Q1 2022
Shares 2,029,701 Value ($000) $44,552 Avg Close $20.24 Range $16.53 - $28.95
Q4 2021
Shares 2,029,701 Value ($000) $57,664 Avg Close $24.65 Range $18.97 - $28.82
Q3 2021
Shares 1,679,701 Value ($000) $35,358 Avg Close $20.92 Range $16.68 - $25.50
Q2 2021
Shares 1,679,701 Value ($000) $31,662 Avg Close $17.57 Range $15.15 - $21.64
Q1 2021
Shares 1,071,428 Value ($000) $16,371 Avg Close $15.50 Range $13.29 - $18.09
Q4 2020
Shares 1,071,428 Value ($000) $15,118 Avg Close $13.93 Range $11.61 - $17.84
Q3 2020
Shares 1,071,428 Value ($000) $16,789 Avg Close $15.29 Range $13.12 - $18.12
Q2 2020
Shares 1,071,428 Value ($000) $18,771 Avg Close $17.05 Range $12.50 - $23.70